Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06627205 · ClinicalTrials.gov registry record · NA
Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism
A NA study of Autism and Autism Spectrum Disorder (ASD), sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06627205: Recruiting NA study of Autism and Autism Spectrum Disorder (ASD), sponsored by Stanford University.
NCT06627205 is a NA study of Autism and Autism Spectrum Disorder (ASD) that is actively recruiting participants, run by Stanford University. The registered enrollment target is 25 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06627205, a NA study of Autism and Autism Spectrum Disorder (ASD), is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of parent-training in delivering the intervention.
Primary Outcome
Acceptability will be assessed using a series of questions rated by participants on a 5-point Likert scale (1-5) with 1 being the least acceptable and 5 being the most acceptable.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Restriction Therapy
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06627205 shows while recruiting
NCT06627205 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Sleep Restriction Therapy is the first listed.
NCT06627205 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06627205 about?
NCT06627205 is a clinical study titled "Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism". The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist ...
What is the current status of trial NCT06627205?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-02-11. Estimated completion is 2027-12.
What conditions does trial NCT06627205 study?
This clinical trial studies the following conditions: Autism, Autism Spectrum Disorder (ASD).
What interventions are being tested in trial NCT06627205?
The interventions under investigation include: Sleep Restriction Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06627205?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06627205 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06627205's enrollment target sits among peer trials
25 82nd of 104 higher than 20 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI